Fundz

Delfi Diagnostics reported raising $34.3 Million in an initial SEC Form D filing, from an offering of $60 Million

PRIVATEDec 18, 2025$34.3M of $60M raised

Amount Raised

$34.3 Million

$34.3 Million sold, per SEC Form D (first sale Dec 1, 2025)

Round Type

Venture

BaltimoreBiotechnology

Quick answer

DELFI Diagnostics raised $34.3 Million in a funding round, dated December 1, 2025. DELFI Diagnostics is based in Baltimore, Maryland, United States.

How much did DELFI Diagnostics raise?
DELFI Diagnostics raised $34.3 Million in a funding round on December 1, 2025.
What does DELFI Diagnostics do?
DELFI Diagnostics is developing next-generation blood-based cancer detection tests designed to be accurate, accessible, and scalable for population health.
Where is DELFI Diagnostics based and how big is it?
DELFI Diagnostics is based in Baltimore, Maryland, United States. Fundz records about 171 employees.
Who are the decision-makers at DELFI Diagnostics?
Fundz holds 3 contacts at DELFI Diagnostics, including the Vice President Quality Regulatory & Lab Operations. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as DELFI Diagnostics that raised within 45 days of this round, from Fundz verified event records.

  • CRB raised $50M on January 15, 2026.
  • Transition Metal Solutions raised $6M (Seed) on January 15, 2026.
  • SenseUP raised $3.5M (Seed) on January 15, 2026.
  • Cantai Therapeutics raised $3M (Seed) on January 15, 2026.
  • Science&Humans raised $7.9M (Series A) on January 15, 2026.
  • MARS Bioimaging raised $15M (Series A) on January 14, 2026.

Who to call at DELFI Diagnostics, and when

A new round usually means DELFI Diagnostics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day DELFI Diagnostics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at DELFI Diagnostics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at DELFI Diagnostics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

DELFI Diagnostics

Location

1810 Embarcadero Road

Baltimore, Maryland, United States

About

DELFI Diagnostics is developing next-generation blood-based cancer detection tests designed to be accurate, accessible, and scalable for population health. Its technology is based on fragmentomics, using machine learning to analyze patterns in cell-free DNA from a simple blood draw. DELFI’s first test, FirstLook Lung, supports lung cancer screening by reliably identifying individuals who may have cancer, including early-stage disease, with a 99.8% negative predictive value.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment DELFI Diagnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsMichaela H., Vice President Quality Regulatory & Lab… hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for DELFI Diagnostics's next move

See what Strategic adds

DELFI Diagnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.